Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results


1.		Cost-Effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Natural history/Epidemiology, Supportive care				Active				18 and over				Pharmaceutical / Industry				CR002455 NCT00264108


2.		R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-Cell Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				66 to 80				Other				LNH03-6B NCT00144755

Last Modified: 3/6/2008 First Published: 1/20/2006


3.		Phase III Study of Fludarabine and Darbepoetin alfa in Geriatric Patients With Chronic Lymphocytic Leukemia and Comorbidities

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Geriatric				Other, Pharmaceutical / Industry				GCLLSG-CLL9 EU-20561, AMGEN-GCLLSG-CLL9, EUDRACT-2005-003014-15, NCT00281892

Last Modified: 8/25/2008 First Published: 4/17/2008


4.		Phase III Randomized Study of Darbepoetin Alfa With or Without Iron Supplementation Comprising Ferrous Sulfate or Sodium Ferric Gluconate Complex in Cancer Patients With Chemotherapy-Associated Anemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				NCI				MAYO-MC04CC MC04CC, NCT00661999


5.		Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Active				18 to 65				Other				jth_004 NCT00204633


6.		Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				GFM-DAR500-2006-01 NCT00443339

Last Modified: 3/30/2006 First Published: 3/24/2006


7.		Randomized Study of Adjuvant Chemotherapy With Versus Without Darbepoetin alfa in Women With Stage III Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Active				18 to 65				Other, Pharmaceutical / Industry				WGSG-ARA-PLUS AVENTIS-WGSG-ARA-PLUS, SANOFI-WGSF-ARA-PLUS, EU-205108, NCT00309920

Last Modified: 4/3/2008 First Published: 12/21/2006


8.		Pilot Randomized Study of Epoetin alfa or Darbepoetin alfa in Patients With Chemotherapy-Associated Anemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Active				18 and over				NCI, Pharmaceutical / Industry				MCCRC-RC05CB MCCRC-06-002991, ORTHO-MCCRC-RC05CB, NCT00416624

Select All on One Page